首页/数据集/The effect of delayed treatment in breast cancer patients: how much is too late? An experience of a single-center study

The effect of delayed treatment in breast cancer patients: how much is too late? An experience of a single-center study

Name: The effect of delayed treatment in breast cancer patients: how much is too late? An experience of a single-center study
Creator: Felipe Andrés Cordero da Luz
Published: 2026-04-09T12:25:42+08:00

Mendeley Data2026-04-09 收录

乳腺癌治疗

临床结果分析

数据链接：

https://data.mendeley.com/datasets/r73wsfffn5 数据链接链接失效反馈

官方服务：

资源简介：

Dataset to analyze the influence of time to surgery, or any first treatment, on important breast cancer outcomes.

应用场景：

提供机构：

Felipe Andrés Cordero da Luz

乳腺癌治疗

市场分析

Global metastatic breast cancer treatment market size is expected to reach $30.51 Bn by 2028 at a rate of 11.2%, segmented as by therapy type, chemotherapy, radiation therapy, biologic targeted therap

www.thebusinessresearchcompany.com160

AS1411-conjugated doxorubicin-loaded silver nanotriangles for targeted chemo–photothermal therapy of breast cancer - supplementary data

乳腺癌治疗

纳米医学

Background: Combination therapy has attracted tremendous interest for its great potential in treating cancers. Materials & methods: Based on chitosan-coated silver nanotriangles, polyethylene glycol,

future-science-group.figshare.com2024-05-16 更新90

A phase II trial evaluating the efficacy and safety of epirubicin and cyclophosphamide (EC) followed by docetaxel with gemcitabine (DG) (+trastuzumab if HER2-positive) as neoadjuvant chemotherapy for women with large operable or locally advanced breast carcinoma (ANZ 0502 NeoGem)

乳腺癌治疗

临床试验

HeSANDA 1.0.0

DataCite Commons2023-06-08 更新60

Network pharmacology-based screening of active constituents of Avicennia marina and their clinical biochemistry related mechanism against breast cancer

乳腺癌治疗

网络药理学

Breast cancer is the second major cause of cancer death in women globally. Avicennia marina is a medicinal plant that belongs to the family Acanthaceae and is known as grey or white mangrove. I

DataCite Commons2024-05-15 更新100

The impact of antioxidant supplements on the risk of recurrence, mortality, inflammatory markers, and patient-reported outcomes in women with breast cancer: A systematic review

乳腺癌治疗

抗氧化剂

Abstract Purpose: Many breast cancer (BC) patients take antioxidant supplements during cancer therapy to improve health outcomes, but little is known about their benefits. This systemati

DataCite Commons2021-07-02 更新90

The effect of delayed treatment in breast cancer patients: how much is too late? An experience of a single-center study

资源简介：

相关数据集